Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
clinical trials
fda
boston
boston top stories
deals
detroit blog main
detroit top stories
national top stories
san francisco blog main
aimmune therapeutics
akouos
allergy
anaphylaxis
andrew oxtoby
astellas pharmaceuticals
bempedoic acid
biopharma
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cholesterol
corticosteroids
daniel edelman
decibel therapeutics
detroit
duchenne
eosinophilic esophagitis
esperion therapeutics
europe blog main
europe top stories
ezetimibe
fluoroquinolones
food allergy
frequency therapeutics
harvard university
hearing loss
What
fda
4
×
therapeutics
4
×
approved
drug
approval
medicines
second
therapy
treat
won
affects
agency
aimmune
allergy
americans
awarded
betting
billion
biopharma
cholesterol
combo
date
deal
developed
developing
duchenne
esperion
esperion’s
frequency
friday
gene
hearing
historic
immunotherapy
ipo
late
levels
loss
lowering
medicine
Language
unset
4
×
Current search:
unset
×
therapeutics
×
fda
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
